InVivo NSA has acquired AdGène
July 2015 — InVivo NSA has acquired AdGène for US$8 million.
InVivo NSA, along with its subsidiaries, engages in complete feed, premix, additives, analysis laboratories, and animal health businesses in Central America, South America, France/EMEA, and Asia. InVivo Labs, the analytical division of InVivo NSA, and AdGène, an expert laboratory in molecular biology in France, have announced their strategic union. This transaction allows InVivo Labs to reinforce its analytical portfolio related to food safety and traceability. Moreover, it positions the new group as a significant player in the high potential growing market of bioanalysis.
Founded in 2001, AdGène is a French laboratory that specializes in molecular biology, genetic analyses and water quality control. The laboratory employs 20 people and has high-tech equipment.
Our role in the transaction
Oaklins' team in France advised the buyer in this transaction.
Talk to the deal team
Related deals
Terhills Resort by Center Parcs has been acquired by TwentyTwo Real Estate
Terhills Resort, a premium resort in Belgium combining luxury and nature located near Hoge Kempen National Park and operated by Center Parcs, has been sold by venture capitalist LRM to TwentyTwo Real Estate, an independent real estate investor and operator. Both the real estate and the operations were included in the transaction, and Center Parcs is staying on board as an operational partner.
Learn moreBolster Investment Partners has secured debt financing for the acquisition of Royal Taste Company
Bolster Investment Partners has partnered with Royal Taste Company, a leading Dutch custom signature coffee platform offering end-to-end sourcing, blending, roasting, packaging and delivery services. The partnership marks an important next step in Royal Taste Company’s growth trajectory, focused on further geographical expansion, commercial development and selective strategic acquisitions.
Learn moreUKAT Group has acquired Bayberry Limited
UK Addiction Treatment (UKAT) Group, a leading UK provider of residential addiction, mental health and behavioral health treatment backed by Sullivan Street Partners, has acquired Bayberry Limited, a specialist mental health and wellbeing treatment provider. Joining UKAT enables Bayberry to preserve continuity of care for patients and referral partners, retain the strength of its clinical team and benefit from UKAT’s operational infrastructure, referral network and marketing channels. This partnership supports Bayberry’s next stage of development while preserving the qualities that differentiate its service offering.
Learn more